Want to know how much Jeremy Levin makes? You'll soon find out. The numbers on Teva Pharmaceutical Industries' CEO pay will finally go public, now that the company has settled a lawsuit from investors angry about the compensation secrecy.
California's Vertos Medical has closed $23 million in financing, cash the company will use to expand the market for its pain-reducing spinal surgery device.
Washington's Mirabilis Medica has closed $7 million in financing for its ultrasound-based uterine fibroid treatment, part of a Series A that could reach $13 million.
The good news from IMS Institute for Healthcare Informatics: Using prescription medicines properly could save $200 billion in annual U.S. healthcare costs. More good news, at least for the pharma business: The institute's ideas for saving money don't all translate to less spending on drugs, branded or otherwise.
Exact Sciences is looking to haul in $63.7 million through a stock sale, cash the company needs to get its stool-based cancer diagnostic through the FDA process and onto U.S. shelves.
Bioresorbable cardiovascular stents are gaining momentum and drawing more investor interest. This time, the spotlight falls on Amaranth Medical, which is well underway with plans to raise a $25 million Series B funding round.
Veniti, a Missouri device startup developing venous disease treatments, has nailed down more than $9.7 million of an anticipated $12 million round of venture financing from 15 investors, according to a regulatory filing.
Within a year of its launch, North Carolina's NeuroTronik has closed a $13.1 million Series A to develop a device that treats heart failure with neuromodulation.
On Tuesday, the SEC filed civil complaints against two brothers accused of buying stock based on secret knowledge of the then-upcoming takeover--the 8th case the Commission has brought against insider trading connected to that deal, it says.
Thermo Fisher has released details concerning the execution of a $2.2 billion sale of common stock--a massive undertaking designed to help cover its $13.6 billion bid to buy Life Technologies.